Growth Factor Serum for Microneedling: Benefits & Risks

A well-run microneedling service combines effective technology with thoughtful patient care. If your practice is considering a growth factor serum for microneedling, start by asking practical questions. Is the product labeled for the intended use? Is it sterile or packaged for single use? Can it be used with your device? What evidence supports the finished formula? How should staff store, apply, and document it? These answers help create a safer, more consistent experience for patients and providers. With the right training, product review, aftercare, and follow-up process, practices can add this option to their services with greater clarity and confidence.

Key Takeaways

• Vet every serum before use: Confirm professional-use labeling, sterility, ingredients, storage requirements, product evidence, and compatibility with the microneedling system.
• Standardize the complete treatment process: Screen patients, select conservative settings, train staff, track product lots, document consent, and provide clear recovery instructions.
• Communicate benefits and risks honestly: Explain that improvements develop gradually and vary by patient, then outline expected reactions, warning signs, and follow-up care.

What Is Growth Factor Serum for Microneedling?

Growth factor serum is a topical formulation used to support the skin’s recovery after microneedling. Depending on the product, it may contain growth factors, peptides, hyaluronic acid, conditioned media, recombinant proteins, platelet-derived components, or other ingredients intended to condition the skin. Because formulas vary widely, practices should evaluate the finished product, its labeling, and its intended use rather than relying on a single ingredient name.

Microneedling creates controlled micro-injuries that prompt the skin to begin a repair response. When a suitable topical serum is included in a professional protocol, it may help support hydration and comfort while the treated area recovers. It does not replace patient screening, sterile handling, appropriate aftercare, or sound device technique. Practices using systems such as CytoPen® microneedling pens should confirm that any serum is compatible with the device and approved for the intended procedure.

It is also important to separate skin biology from promotional language. Growth factor serums may help improve the appearance of texture, hydration, and fine lines for some patients, but they are topical products, not injectable therapies. Results depend on the patient’s skin, treatment plan, product formulation, and recovery habits.

A clear protocol should define which product is used, when it is applied, how it is stored, and what patients should use at home. That consistency helps providers assess outcomes more accurately and identify irritation or other adverse reactions early.

Growth Factors vs. Growth Hormone

Growth factors and growth hormone are different substances with different roles in the body. Growth factors are naturally occurring proteins that act as local messengers. They help guide processes such as cell growth, tissue repair, and regeneration. Growth hormone is produced by the pituitary gland and influences growth and metabolism through broader, systemic pathways.

In skin care, a growth factor serum generally refers to a topical product containing selected signaling proteins or related ingredients. It does not provide the same function as growth hormone, and it should not be presented as a hormone treatment. Natural growth factor activity can change with age, which may contribute to slower skin renewal, reduced firmness, and visible lines. A topical formula is intended to support the skin’s surface during recovery, not replace the body’s endocrine system.

Practices can review a plain-language explanation of this distinction in MDPen’s guide to human-derived growth factor serum. Patient education should explain that a topical product works locally and should avoid suggesting that it creates whole-body effects.

EGF, FGF, TGF-β, and PDGF in Skin Repair

Several growth factor families are associated with tissue repair and skin remodeling. Epidermal growth factor, or EGF, is involved in signals that support epidermal cell activity. Fibroblast growth factors, known as FGF, are linked with fibroblast behavior and tissue repair. Transforming growth factor beta, or TGF-β, helps regulate inflammation and extracellular matrix production. Platelet-derived growth factor, or PDGF, also participates in communication between cells during repair.

These proteins do not work as isolated repair switches. Their activity depends on concentration, formulation, stability, delivery, and the condition of the skin. They also function within a broader network of signals that changes throughout healing. Growth factors can signal fibroblasts to produce structural proteins such as collagen and elastin, which help support firmness and elasticity.

For a useful overview of these pathways, Optima Dermatology explains the role of growth factors in skin repair. This biology helps explain why growth factor formulas may be included in microneedling protocols, but it does not guarantee a specific cosmetic result for every patient.

Conditioned Media, Recombinant Proteins, Peptides, Hyaluronic Acid, PRP, and Exosomes

Growth factor serums can be made with different types of ingredients, and these categories are not interchangeable. Conditioned media is a fluid collected after cells have been cultured. It may contain growth factors, peptides, and other cellular signals. Recombinant proteins are produced using biotechnology, which can provide greater consistency for a selected protein. Peptides are smaller chains of amino acids that may support signaling or skin conditioning, while hyaluronic acid primarily helps attract and retain water.

Platelet-rich plasma, or PRP, is prepared from a patient’s own blood and delivered through a clinical procedure rather than used as an ordinary cosmetic serum. Exosomes are small extracellular vesicles involved in cell-to-cell communication. Their source, processing, purity, and clinical evidence can vary considerably. Practices should review the specific product instead of treating “growth factor,” “stem cell,” or “exosome” as proof of effectiveness.

MDPen’s overview of growth factor serum ingredients provides additional background on conditioned media, peptides, and exosomes. Any product used during microneedling should also have clear instructions for professional use, appropriate safety documentation, and handling requirements that staff can follow consistently.

How Microneedling Creates Temporary Microchannels

Microneedling uses sterile needles to create controlled punctures in the skin. These openings are temporary microchannels. They can increase contact between a procedure-specific topical product and the treated tissue while also initiating the skin’s natural healing response.

The channels are not permanent pathways, and they should not be treated as permission to apply any serum. A product that is acceptable for use on intact skin may contain preservatives, fragrances, or other ingredients that are not appropriate for freshly treated skin. The formula must be designed and labeled for the intended application, with sterile handling maintained throughout the procedure.

Microneedling technique also changes the treatment experience. Needle depth, pressure, number of passes, and the endpoint selected by the provider influence the degree of skin disruption. Emage Medical’s microneedling technologies can help practices review device options and available training resources. The serum supports the protocol, but it cannot correct excessive passes or unsuitable settings.

How Cells Signal During Collagen Remodeling

After microneedling, the skin moves through overlapping stages of inflammation, repair, and remodeling. Growth factors and other signaling molecules help coordinate this activity. Fibroblasts, the cells responsible for producing key components of the extracellular matrix, may receive signals to create collagen and elastin. Over time, this remodeling can contribute to changes in the appearance of texture, fine lines, and mild laxity.

This process takes time. A serum does not place new collagen directly into the skin, and it cannot make every patient respond in the same way. Age, baseline skin condition, treatment intensity, sun exposure, smoking, health conditions, and aftercare can all influence recovery and visible results.

For providers, the practical takeaway is to describe growth factors as supportive signals within a broader healing process. MDPen’s discussion of collagen remodeling offers more context on how growth factors interact with fibroblasts and structural proteins. Patient expectations should focus on gradual changes rather than an immediate transformation.

What Topical Growth Factors Can and Cannot Do

Topical growth factor products may help improve the appearance of hydration, texture, fine lines, and overall skin quality when used appropriately. Some patients may also notice a more comfortable recovery after treatment, although the experience depends on the formula and individual sensitivity. These products are best viewed as one part of a complete microneedling plan.

They cannot replace professional assessment, careful device technique, or treatment for an underlying skin condition. They also cannot replicate the results of injectables, surgery, or every in-office procedure. A topical serum will not automatically correct significant laxity, deep scars, pronounced wrinkles, or advanced pigmentation.

Practices should keep claims specific and supportable. Rather than promising regeneration or guaranteed rejuvenation, explain what the product is intended to do and how results will be assessed. Skincredible’s discussion of microneedling with human growth factor also emphasizes that topical growth factors are supportive products, not substitutes for professional treatments or injectable procedures.

Why Enhanced Absorption Does Not Make Serum Injectable

Microneedling may increase the absorption of a topical product through temporary microchannels, but that does not make the product suitable for injection. Topical and injectable products differ in formulation, sterility requirements, manufacturing controls, delivery method, and regulatory classification. A serum intended for surface application should never be injected unless it is separately authorized and specifically labeled for injection by the appropriate regulatory authority.

The same rule applies to products marketed with terms such as “medical grade,” “professional strength,” or “stem cell.” These descriptions do not establish that a formula is injectable or safe for use beyond its labeled purpose. Providers should follow the product instructions, device guidance, and applicable clinical regulations.

Doctorly’s explanation of growth factors makes this distinction clear: improved topical absorption changes how a product reaches the skin, not what the product is. Keeping topical and injectable treatments separate protects patients and supports responsible clinical practice.

Why Use Growth Factor Serum With Microneedling?

Microneedling creates controlled micro-injuries that activate the skin’s natural repair response. As the treated tissue recovers, collagen production and tissue remodeling may gradually improve the appearance of fine lines, uneven texture, mild laxity, and some acne scars. A growth factor serum may complement this process by providing signaling proteins and hydrating ingredients to the treatment area.

The serum is not a substitute for proper technique, patient screening, or aftercare. Results depend on the formula, device settings, needle depth, number of passes, treatment endpoint, and the patient’s skin condition. Practices should select a product labeled for professional microneedling or post-procedure use and follow the serum and device manufacturer’s instructions. Emage Medical provides microneedling technologies and practice support for providers developing consistent treatment protocols.

Support Barrier Recovery, Hydration, and Comfort

Microneedling temporarily disrupts the skin barrier, so patients may experience warmth, redness, tightness, dryness, or sensitivity after treatment. A properly formulated post-procedure serum may support hydration while the barrier recovers. Ingredients such as hyaluronic acid help attract and retain water at the skin’s surface, which may ease feelings of dryness and tightness.

Growth factors are signaling proteins involved in cell communication and tissue repair. The Baylor College of Medicine describes their role in skin renewal, although topical formulas differ in source, concentration, stability, and supporting evidence.

Comfort should remain a treatment goal, not a guarantee. A product that works well on intact skin may irritate freshly treated skin if it contains fragrance, alcohol, strong acids, retinoids, or other unnecessary actives. Use a sterile, procedure-specific formula after microneedling, then provide clear instructions for gentle cleansing, moisturization, and sun protection during recovery.

Remodel Collagen to Address Fine Lines, Texture, Laxity, and Acne Scars

Microneedling’s primary effect comes from controlled stimulation of the skin’s repair response. Fibroblasts, which produce collagen and other structural proteins, become active as the tissue remodels. Over time, this process may soften the appearance of fine lines, refine uneven texture, and make mild laxity appear less noticeable.

A growth factor serum may complement remodeling by providing signals associated with repair and regeneration. A review of microneedling with growth factors discusses potential improvements in skin texture and related treatment outcomes. However, the serum is only one part of the protocol. Device selection, treatment settings, patient characteristics, and aftercare also influence results.

Acne scars require an individualized assessment. Rolling scars may respond differently from boxcar or ice-pick scars, while deeper scars may need a combination of procedures. A topical serum cannot release tethered scar tissue or replace treatments intended for deeper remodeling. Providers should assess scar type, skin tone, pigment-change history, and expected downtime before recommending treatment.

Potential Changes in Firmness, Redness, Tone, and Healing

Redness, warmth, swelling, sensitivity, and pinpoint bleeding can occur immediately after microneedling. These effects reflect the treatment response and typically improve as the barrier recovers. A suitable serum may support hydration and comfort, but practices should not promise that it will eliminate redness or guarantee faster healing.

Some research suggests that growth factor formulas applied after microneedling may improve measures such as wrinkle depth, texture, and firmness compared with microneedling alone. One reported clinical study found changes as early as four weeks, but that timeline should not be presented as typical for every patient or formula.

Tone changes require careful monitoring. Inflammation may temporarily make discoloration more noticeable, especially for patients prone to post-inflammatory hyperpigmentation. Conservative settings, appropriate treatment intervals, and consistent sun protection can help limit unnecessary irritation. Capture baseline images of redness, pigmentation, and texture so the team can track recovery and identify unexpected changes.

Compare Microneedling With and Without Growth Factor Serum

A practical way to assess a serum is to compare outcomes with a consistent control. Research has used split-face designs, treating one side with microneedling plus a growth factor formula and the other with microneedling alone or another product. One reported split-face comparison found greater improvement in periorbital wrinkles and laxity on the side treated with growth factor serum.

These findings do not mean every product will produce the same outcome. The term “growth factor serum” may describe human-derived proteins, recombinant ingredients, conditioned media, peptide blends, or formulas that also contain hyaluronic acid. The finished product, application method, device settings, and follow-up period all affect the interpretation.

For a meaningful comparison, keep the device, needle depth, passes, anesthetic, aftercare, photography, lighting, and evaluation schedule consistent. Record the exact product and lot number. Patient feedback also matters, including comfort, tightness, redness, and downtime, alongside photographs and clinical assessments.

How Needle Depth, Passes, Skin Condition, and Aftercare Shape Results

Serum performance cannot be separated from treatment technique. Needle depth determines how deeply the tissue is affected, while the number of passes and applied pressure influence treatment intensity. More aggressive treatment is not automatically better. Excessive passes may increase inflammation, discomfort, prolonged redness, and pigment-change risk without providing a proportional improvement.

The patient’s skin condition also shapes safety and results. Active acne, infection, dermatitis, sunburn, or barrier damage may increase complication risk and could require postponing treatment. Review medical history, medications, healing concerns, and previous reactions before choosing settings or products.

Aftercare supports the early repair phase. Patients generally need gentle cleansing, a bland moisturizer when appropriate, daily sun protection, and a temporary break from irritating active ingredients. Practices using CytoPen® or StemFacial® systems should follow the applicable manufacturer protocols for product compatibility, application, cleaning, and post-treatment monitoring.

What Does the Evidence Say About Growth Factor Serum?

Research on growth factor serum used with microneedling is promising, but the evidence is not uniform. Available research includes laboratory studies on cell signaling, clinical studies involving small patient groups, split-face comparisons, and broader reviews of microneedling and regenerative ingredients. Each type of evidence answers a different question. Laboratory research can explain how an ingredient may affect skin cells, while clinical research can show whether patients experience visible changes. Reviews help identify broader patterns and limitations across multiple studies.

For aesthetic practices, the most useful question is not simply whether growth factors “work.” It is whether a specific, properly labeled product has evidence for its intended use, whether it is appropriate for application after a controlled microneedling procedure, and whether the protocol supports realistic patient expectations. The microneedling research literature supports the role of controlled skin injury in collagen remodeling, while also showing how outcomes can vary based on devices, treatment settings, products, and study design.

Compare Mechanistic, Laboratory, Clinical, and Review Evidence

Mechanistic evidence explains how growth factors may influence skin repair. Laboratory studies can identify changes in fibroblast activity, collagen production, wound-healing signals, and communication between cells. This information helps explain why a serum could support recovery after microneedling. However, it does not prove that patients will experience a specific degree of wrinkle reduction, scar improvement, or firmness.

Clinical evidence is more useful for treatment decisions because it measures changes in people. Even so, clinical studies can differ considerably in their methods. Researchers may use different needle depths, treatment intervals, serum formulas, imaging systems, grading scales, and follow-up periods. Review articles bring these findings together and may reveal consistent patterns, but their conclusions remain limited by the quality of the studies they include. A review of topical growth factors with microneedling provides helpful context for weighing both potential benefits and gaps in the research.

Interpret the Reported 17.6% Texture and 17.3% Wrinkle Improvements

Some reports cite a 17.6% improvement in skin texture and a 17.3% improvement in wrinkles after participants received growth factor serum with microneedling. These figures may sound precise, but they need context. A percentage can represent an average change from a baseline score, an image-based measurement, or an evaluator’s assessment. It does not mean that every patient experienced the same result, nor does it prove that the serum alone caused the improvement.

The comparison group also matters. If both groups received microneedling and only one received growth factor serum, the findings may suggest an added benefit from the serum. Without a microneedling-only group, it becomes more difficult to separate the effects of the procedure from those of the topical formula. Before using these figures in patient conversations or marketing, practices should review the original study’s methods, patient population, serum identity, treatment protocol, and follow-up period.

Review Findings on Wrinkles, Elasticity, Firmness, Scars, Pigmentation, and Hydration

Clinical reports have associated growth factor treatments with improvements in several skin measures, including fine lines, texture, firmness, elasticity, hydration, and the appearance of acne scars. Some studies also describe changes in redness and uneven pigmentation. These outcomes are biologically plausible because microneedling initiates a repair response, while selected topical ingredients may support the skin during recovery.

The strength of evidence is not equal for every concern. Texture and fine lines are common endpoints in microneedling research, while pigmentation and scar improvement can be more difficult to measure consistently. Hydration may improve temporarily as the barrier recovers and the formula adds moisture, but this does not necessarily indicate long-term structural change. A comprehensive review of microneedling applications offers useful context when evaluating results across different treatment goals.

Examine Split-Face Studies and Early Results Around Four Weeks

Split-face studies can provide a useful comparison because each participant receives a different treatment on each side of the face. This design helps account for differences in age, skin type, lifestyle, and baseline skin condition. When the side treated with growth factor serum shows greater improvement than the comparison side, the finding may support an added effect from the formula.

The design still has limitations. Participants and evaluators may recognize which side received the additional product, and differences in application or healing can influence the findings. Changes seen around four weeks may reflect reduced inflammation, improved hydration, or early remodeling rather than the final outcome. Collagen remodeling continues over time, so practices should explain that an early assessment cannot predict each patient’s longer-term response. Consistent photographs and follow-up intervals make these changes easier to evaluate.

Compare Skin Rejuvenation and Hair-Restoration Evidence

Evidence for growth factor serum is more developed in discussions of skin repair and rejuvenation than in standardized hair-restoration protocols. Skin studies commonly evaluate wrinkles, texture, elasticity, firmness, and scars after procedures such as microneedling. Hair studies may measure density, shaft thickness, shedding, or photographic improvement, but they often use different devices, application methods, treatment schedules, and outcome measures.

Microneedling may influence the scalp through controlled injury and local signaling, but a topical growth factor serum should not replace a diagnosis or an established hair-loss treatment. Hair thinning can result from hormonal changes, nutritional deficiencies, inflammation, medication effects, and hereditary factors. Practices offering hair-restoration services should complete an appropriate clinical assessment and review evidence for the specific product and protocol. Emage Medical’s hair-restoration technologies can help practices consider device-based options within a broader treatment plan.

Distinguish Evidence for Growth Factors, Conditioned Media, PRP, and Exosomes

These terms are often grouped together, but they describe different materials. A growth factor formula may contain selected proteins produced through recombinant methods or obtained from a biological source. Conditioned media contains substances released by cultured cells, and its composition can vary based on the cell type, culture process, and processing methods. PRP is prepared from a patient’s own blood and contains platelets, plasma, and signaling proteins.

Exosome products raise additional questions about their source, manufacturing, characterization, sterility, and regulatory status. Evidence for one category cannot automatically be applied to another. Even products with similar marketing language may differ in concentration, purity, stability, and intended use. Practices should request product-specific documentation and avoid describing all regenerative ingredients as interchangeable. The FDA’s information on exosome products is a useful resource for evaluating claims and answering patient questions.

Account for Formula Variability, Small Samples, Short Follow-Up, and Other Limits

One major limitation in this field is product variability. “Growth factor serum” does not identify one standardized formula. Products may differ in ingredients, concentrations, source materials, preservatives, packaging, and manufacturing controls. These differences make it difficult to compare studies or assume that findings for one product apply to another.

Many studies also include few participants and follow them for a limited period. Small samples may not represent the range of skin types, ages, medical histories, and treatment goals seen in practice. Short follow-up can capture early improvement without showing how long it lasts or whether delayed irritation or pigment changes occur. Other limitations include inconsistent photography, subjective grading, limited blinding, and combined treatments that make it difficult to identify which component produced the result. A published assessment of microneedling with topical growth factors outlines several of these concerns.

Discuss Potential Benefits Without Guaranteeing Results

The evidence supports presenting growth factor serum as a possible addition to microneedling, not as a guaranteed way to improve every patient’s skin. Patients may notice smoother texture, softer fine lines, improved hydration, or gradual changes in the appearance of scars and laxity. The extent and timing of improvement can differ based on age, skin condition, treatment settings, serum formulation, healing response, sun exposure, and aftercare.

Practices should use specific, supportable language. Rather than promising wrinkle removal or dramatic rejuvenation, explain that the treatment may support the skin’s repair process and complement controlled microneedling. Before-and-after photographs should use consistent lighting, positioning, and time intervals, and should not imply that one patient’s result is typical for everyone. Appropriate patient selection, a structured protocol, and ongoing training, such as the support available through Emage Medical’s practice resources, can help teams apply the evidence responsibly.

Which Growth Factor Serum Types Suit Professional Microneedling?

Professional microneedling serums should be selected for the procedure, not simply for an appealing ingredient list. Microneedling creates temporary microchannels in the skin, so any product used during or immediately after treatment should have appropriate labeling, sterility controls, and compatibility with the device and protocol. A serum designed for daily use on intact skin may not be suitable for freshly treated skin.

Growth factor formulas can vary in their sourcing, processing, concentration, and supporting ingredients. Some contain human-derived proteins or conditioned media, while others use recombinant proteins, peptides, hyaluronic acid, or exosome-related ingredients. Practices should evaluate the finished product, review the available evidence, and follow the manufacturer’s instructions. Emage Medical’s microneedling technologies can help practices align product selection with their treatment workflow and device protocols.

Evaluate Human-Derived Growth Factors and Donor-Screened Conditioned Media

Human-derived growth factor formulas are produced using donated human cells. The finished serum contains proteins and cellular signals released by those cells, not the cells themselves. These signals may support communication involved in skin repair and collagen remodeling, though the quality of the final product depends on sourcing, processing, purification, concentration, and manufacturing controls.

Ask the supplier whether donors are screened, how the material is processed, and whether the finished product undergoes sterility and contamination testing. Donor-derived products should also include clear labeling and storage instructions. Review the product’s intended use instead of relying on broad claims about “human” ingredients. This overview of human-derived growth factor serums explains how these formulas compare with other growth factor categories.

Consider Recombinant Growth Factors and Formulation Consistency

Recombinant growth factors are produced through laboratory methods designed to create specific proteins. A formula may include signals associated with collagen production, cell migration, or tissue repair. Because recombinant products are engineered for a defined purpose, they may offer a more predictable composition from one batch to the next than some complex biological mixtures.

Consistency still depends on the finished formulation. Storage conditions, pH, concentration, stabilizers, and packaging can affect product quality and performance. Look for documentation about manufacturing and testing, along with clear instructions for microneedling use. Ingredient names alone do not establish clinical effectiveness. Reviewing the differences between recombinant and human-derived growth factors can help providers ask more specific questions when comparing products.

Review Stem Cell-Conditioned Media and Secretome-Based Formulas

Stem cell-conditioned media contains substances released by cultured cells, including growth factors, peptides, and other signaling molecules. Secretome-based products use a similar approach, focusing on collected cellular signals rather than live stem cells. These formulas are often marketed for skin repair, regeneration, and improved texture.

The label should identify the source of the conditioned media and explain how it was processed. Practices should also confirm whether the available evidence applies to the exact product, concentration, and microneedling protocol they plan to use. Research on one cell source or formulation does not automatically validate every product in this category. Ask for finished-product testing, storage requirements, and instructions for use on treated skin before adding the serum to a professional protocol.

Assess Exosome Sources, Uncertainty, and Claims

Exosomes are tiny messenger structures that may transport proteins and other signals between cells. Their use in aesthetic treatments has received growing interest, but research is still developing. Products can differ substantially based on their source, purification process, concentration, storage conditions, and quality controls.

Be cautious with claims promising dramatic regeneration, permanent correction, or treatment of medical conditions. Practices should confirm exactly what the product contains, how it is labeled, and whether its intended use is appropriate for microneedling. Providers can review the current discussion of exosomes and growth factors for skin, then compare those general findings with evidence for the specific finished product. Patient counseling should acknowledge uncertainty rather than present emerging ingredients as established treatments.

Consider Hyaluronic Acid, Peptides, and Other Supportive Ingredients

Growth factor serums may include supportive ingredients such as hyaluronic acid, peptides, antioxidants, or soothing compounds. Hyaluronic acid attracts and retains moisture, which may support a plumper appearance and improve the feel of dry, tight skin during barrier recovery. Peptides may support processes involved in producing structural proteins.

These ingredients can complement a microneedling protocol, but a longer ingredient list does not necessarily indicate better results. Avoid formulas containing strong exfoliating acids, retinoids, fragrance, essential oils, or other components that may irritate freshly treated skin. Review the complete ingredient list, not just the featured ingredient, and match the formula to the patient’s sensitivity and treatment goals. A guide to growth factor serum ingredients provides useful context when comparing supportive ingredients.

Choose Sterile, Single-Use, Procedure-Specific Solutions

For professional microneedling, choose a product labeled for the intended procedure and skin application. Sterile, single-use packaging can reduce contamination risk and limit exposure to microorganisms introduced through repeated handling. It also helps staff maintain a consistent setup, application, and disposal process for every patient.

Check whether the serum is intended for use during treatment, immediately afterward, or both. Follow the product and device manufacturer’s instructions for application, storage, and disposal. Do not transfer leftover serum to another container or save an opened vial for a later patient. Sterile, single-use microneedling products are generally preferable to multi-use cosmetic bottles when treatment intentionally disrupts the skin barrier.

Avoid Using Standard Cosmetic Serums in Microneedling Microchannels

A standard cosmetic serum may be suitable for intact skin but inappropriate for freshly treated skin. Cosmetic products can contain preservatives, fragrance, alcohol, acids, retinoids, botanical extracts, or other ingredients that cause stinging and inflammation when they contact microneedling microchannels. A product’s smooth texture or positive reputation does not make it ready for procedural use.

Keep the treatment serum separate from the patient’s at-home skincare routine. During and immediately after microneedling, use only the approved sterile glide or procedure-specific serum listed in the protocol. Give patients clear instructions about when to resume their usual products, and tell them to stop using a product if irritation worsens. This guidance on serums to avoid during microneedling shows why professional treatment products require more careful screening than everyday skincare.

How Can Practices Choose a Growth Factor Serum?

Choosing a growth factor serum for microneedling involves more than comparing ingredient lists or selecting the product with the most impressive marketing language. The serum becomes part of a professional procedure that temporarily changes the skin barrier, so practices should evaluate its intended use, sterility, formulation, storage requirements, device compatibility, and clinical evidence before adding it to a treatment protocol.

A consistent evaluation process also helps teams compare products fairly. Consider the serum alongside the microneedling device, needle depth, treatment goals, patient skin condition, and staff training. Practices should request product documentation from the manufacturer, review applicable regulations, and involve the appropriate medical or compliance professionals when a product’s status or intended use is unclear.

Check Intended Use, Product Labeling, and Regulatory Status

Begin by confirming that the serum is labeled or intended for use with microneedling. A product made for application to intact skin is not automatically appropriate for skin treated with needles. Microneedling creates temporary microchannels, which can change how ingredients interact with the skin and increase the importance of product selection.

Review the complete label, instructions for use, contraindications, manufacturer information, and professional-use requirements. Clarify whether the product is a cosmetic, a device accessory, or another type of regulated product. Marketing language does not establish regulatory clearance or approval. Practices can review the FDA’s guidance on cosmetics and product claims, then consult qualified regulatory professionals when the product’s status is uncertain.

Evaluate Finished-Product Evidence, Not Just Ingredient Claims

A serum may contain a promising growth factor without having strong evidence as a finished product. Ask whether clinical research evaluated the exact formula, delivery method, treatment schedule, and patient population your practice intends to use. Evidence involving a different ingredient, concentration, or microneedling device may not apply directly.

Look for details such as study design, sample size, follow-up period, comparison groups, reported side effects, and measurement methods. Research on topical growth factors used after microneedling has reported changes in texture, firmness, and wrinkle appearance, but each study should be considered within its limitations. A review of growth factor serum evidence can offer helpful background, but it should supplement manufacturer documentation and clinical judgment.

Verify Sterility, Endotoxin Control, Preservatives, and Contamination Prevention

Sterility is a key consideration when selecting a serum for professional microneedling. Since the procedure creates temporary openings in the skin, nonsterile products, contaminated containers, or improper handling may increase the risk of irritation or infection.

Ask the manufacturer how sterility is established and maintained, whether the product is tested for endotoxins, and how contamination is prevented during production and use. Determine whether the serum contains preservatives and whether the formula is labeled for application to recently treated skin. Sealed, single-use packaging may help reduce handling risks, but staff must still follow the product’s instructions for use. Guidance about microneedling and growth factor safety explains why product cleanliness matters during and after treatment.

Review Ingredients, Concentration, pH, and Formulation Stability

Review the complete ingredient list instead of focusing only on the term “growth factor serum.” A formula may also contain hyaluronic acid, peptides, antioxidants, solvents, stabilizers, preservatives, or fragrance. These ingredients can affect tolerability, particularly when applied to recently treated skin.

Ask whether the growth factors remain stable throughout the stated shelf life and whether the manufacturer provides information about concentration, pH, and storage conditions. A skin-compatible pH does not by itself prove that a serum is suitable for microneedling, but it is one useful part of the review. General information about growth factors and skin repair can provide context, while product-specific technical documents should guide clinical decisions.

Confirm Microneedling Device Compatibility and Manufacturer Instructions

The serum should be appropriate for the specific microneedling device, cartridge, treatment depth, and application method used in your practice. Some products are intended for use during treatment as a glide solution. Others are labeled only for application after the procedure. These uses are not interchangeable.

Review the device manufacturer’s instructions before adding a serum to a protocol. Confirm whether the product can be used with the device, whether it may affect needle movement or treatment consistency, and whether any restrictions apply. Practices using CytoPen® microneedling systems should follow the applicable professional protocol and contact Emage Medical when product compatibility or application timing is unclear.

Check Packaging, Storage, Expiration Dates, and Lot Tracking

Packaging can affect a growth factor serum’s stability and safety. Look for sealed containers that protect the formula from light, air, and unnecessary handling. Single-use packaging may limit contamination concerns, while multi-use containers require close attention to opening, dispensing, and discard instructions.

Before each treatment, staff should check the expiration date, package integrity, and storage conditions. Record the product name, lot number, expiration date, and patient use in the treatment record when appropriate. Lot tracking can help a practice respond if a manufacturer issues a notice or a patient reports an unexpected reaction. Do not use products that were frozen, overheated, opened incorrectly, or stored outside labeled conditions without manufacturer guidance.

Match the Formula to Treatment Goals and Skin Sensitivity

The appropriate serum depends on the treatment goal and the patient’s skin. A protocol focused on hydration may call for a different formula than one intended to support the appearance of fine lines, uneven texture, or acne scars. Avoid choosing a product based on one headline ingredient when the complete formula and patient history may have a greater effect on tolerability.

Review known allergies, previous reactions, active skin concerns, and the patient’s current home-care routine. A shorter, well-documented ingredient list may be easier to assess for patients with sensitive skin. Since skin condition can change the treatment plan, postpone or modify treatment when the barrier is impaired. Use the serum according to its labeling and provide appropriate cleansing, moisturization, and sun protection instructions.

Document Patient Consent and Use Compliant Claims

Patient consent should identify the microneedling procedure and the serum being used. It should also explain the serum’s intended role, expected recovery, possible side effects, alternatives, and the possibility of variable results. Document the product name, lot number, treatment settings, application timing, and aftercare instructions in the patient record.

Consultation and marketing language should match the product’s evidence and permitted claims. Do not promise a specific degree of collagen production, wrinkle reduction, scar improvement, or healing time. A topical growth factor serum may support the appearance of treated skin, but it cannot guarantee a particular outcome. It should not be described as injectable unless it is specifically regulated and labeled for that use. Practices can review Emage Medical’s marketing support when developing patient education that is clear, accurate, and consistent with professional standards.

When Should Practices Apply Growth Factor Serum?

The right time to apply growth factor serum depends on the product’s labeling, the patient’s skin condition, the treatment depth, and the device protocol. A serum intended for use on intact skin is not automatically appropriate for application during or immediately after microneedling. Because microneedling temporarily disrupts the skin barrier, every product applied to the treatment area should be selected and handled carefully.

Practices should distinguish between a professional procedure serum and a patient’s at-home skincare product. A professional serum should be labeled for its intended use, while an at-home formula may need to be paused until the skin barrier recovers. Use the product instructions, device guidelines, and clinical judgment to determine when application is appropriate.

Before treatment, explain the serum’s intended purpose, expected recovery, possible reactions, and limitations. Growth factor serum may support a carefully planned procedure, but it cannot guarantee a particular result. Obtain informed consent for both microneedling and the serum, and document the products, settings, and aftercare instructions in the patient record.

Screen Patients, Assess Baseline Skin, and Plan Treatment

Begin with a complete consultation and skin assessment. Ask about current skincare products, allergies, previous reactions, medications, medical conditions, cold sore history, and past microneedling treatments. Examine the treatment area for active acne, infection, dermatitis, eczema, sunburn, open wounds, or visible barrier damage. These findings may require postponing treatment or changing the plan.

Record the patient’s primary concerns, baseline skin condition, and treatment goals. Standardized photos and notes make it easier to distinguish a new reaction from a condition that existed before treatment. Practices can use Image Pro® Skin Imaging Systems to document skin characteristics and support a consistent consultation process.

Review whether the selected serum is intended for use during treatment, immediately afterward, or only on intact skin. Do not rely on ingredient names alone. Confirm that the finished product and its labeling match the planned application.

Patch-Test Intact Skin 24–72 Hours Before Treatment When Appropriate

A patch test may be appropriate when a product is new to the patient, contains several active ingredients, or has previously caused sensitivity. Apply a small amount to clean, intact skin in an inconspicuous area, following the product’s instructions. Observe the site for the period recommended by the manufacturer, which may fall within 24 to 72 hours.

A patch test can identify some irritation or sensitivity, but it cannot predict every reaction. It also does not show that a serum is suitable for use in microneedling channels. The product must still be labeled for the planned professional application.

Tell the patient to report increasing redness, burning, itching, swelling, blistering, or discomfort. If a reaction occurs, do not use the serum and record the finding. The American Academy of Dermatology’s product-testing guidance can support patient education.

Use Only an Approved Sterile Glide or Procedure Serum During Treatment

During microneedling, use only the glide or procedure serum approved by the device and product manufacturers. The product label should identify its intended use, handling requirements, and whether it is sterile and suitable for professional procedures. A standard cosmetic serum may contain fragrance, preservatives, oils, particles, or other ingredients that are not appropriate for use with a microneedling device.

Keep the serum in its original packaging until use. Check the expiration date, lot number, and storage conditions before opening it. Follow single-use requirements, and do not return unused serum to a container. Maintain a clean treatment setup, and prevent bottles, applicators, gloves, and other supplies from contacting nonsterile surfaces.

Device compatibility is equally important. Use the CytoPen® microneedling system according to current manufacturer instructions and training materials. If labeling does not clearly support the planned use, contact the manufacturer before proceeding.

Apply Labeled Serum to Clean, Treated Skin Immediately After Treatment

When a serum is labeled for post-procedure use, apply it at the time specified in the treatment protocol, often after the procedure is complete and the skin has been gently cleansed. The treatment area should be free of makeup, sunscreen, oils, and other products that may increase irritation or interfere with the procedure.

Use the recommended amount. Applying extra product does not necessarily improve absorption or shorten recovery. Dispense the serum with clean technique, and avoid touching the treatment area with contaminated gloves, instruments, or applicators.

Always follow the product’s instructions for timing. Some formulas are intended for use during treatment, while others are designed only for immediate post-treatment use or later home application. If the label does not specify application to treated skin, do not assume it is appropriate. Practices can review the FDA’s information on cosmetic products when evaluating labeling and product claims.

Pat Gently Instead of Rubbing or Massaging Aggressively

Freshly treated skin may feel warm, tight, or sensitive. Apply the serum using a light patting or pressing motion with clean, gloved hands or the applicator specified in the protocol. Avoid vigorous rubbing, massage, or repeated passes over the same area after treatment. Excess friction can increase discomfort and aggravate redness or swelling.

Use a consistent technique that trained team members can repeat. Dispense the prescribed amount, spread it gently across the treatment area, and stop once the skin is evenly covered. Do not use cotton pads, brushes, rollers, or other tools unless the manufacturer specifically permits them.

Give patients the same guidance for home application. They should wash their hands first and avoid rubbing the treated skin when applying serum, moisturizer, or sunscreen during the initial recovery period.

Guide Cleansing, Moisturization, Sun Protection, and Activity During the First 24–72 Hours

Provide written aftercare instructions before the patient leaves. During the first 24 to 72 hours, a simple routine may help limit irritation while the skin barrier recovers. Unless the provider gives different instructions, patients may be directed to use a gentle cleanser, a bland moisturizer, and suitable sun protection.

Ask patients to pause retinoids, exfoliating acids, scrubs, fragrance-heavy products, and other potentially irritating formulas until the practice confirms that the skin has recovered. They should avoid picking, peeling, or flaking the treated area.

Patients may also need to limit strenuous exercise, saunas, swimming, and other activities that create excess heat, sweat, friction, or exposure to unclean water. Give activity instructions based on the treatment depth and the patient’s recovery. The American Academy of Dermatology’s sun protection guidance can support patient education.

Tell Patients When to Restart At-Home Serum and When to Stop

A professional growth factor serum and an at-home serum may require different schedules. Review the home product’s label, ingredients, packaging, and intended use before recommending when to restart it. Some patients may need to wait until warmth, sensitivity, and visible redness have settled. Others may be instructed to use a specific formula sooner if it is labeled for post-procedure care.

Give patients clear instructions about when to stop. They should pause the serum and contact the practice if they develop worsening burning, swelling, itching, hives, blistering, spreading redness, drainage, or pain that does not improve. Breathing difficulty, facial swelling, fever, severe pain, or other signs of a serious reaction require prompt medical evaluation.

Document the instructions in the patient record and provide them in writing. A follow-up message can help patients avoid combining the serum with other active products before the skin is ready.

Adjust Application for Needle Depth, Passes, and Treatment Endpoints

The serum schedule should match the procedure performed. Needle depth, number of passes, treatment area, pressure, pinpoint bleeding, erythema, and the patient’s skin condition all affect the level of skin disruption and expected recovery. A superficial treatment may require different aftercare from a deeper treatment with several passes or a more pronounced endpoint.

Do not increase needle depth or passes simply to justify applying more serum. Establish the treatment endpoint before beginning, then follow the serum and aftercare plan assigned to that endpoint. If the skin becomes unusually reactive, stop and reassess instead of continuing according to a fixed routine.

Record device settings, cartridge or needle information, number of passes, product lot, amount used, and patient response. Consistent documentation helps the practice identify patterns across sessions and refine its protocol responsibly.

Follow CytoPen® and StemFacial® Protocols

Practices using Emage Medical technologies should follow the current training and manufacturer instructions for each system. The CytoPen® and StemFacial® microneedling systems may have specific requirements for preparation, serum selection, application timing, device settings, sanitation, and aftercare. Those instructions should take priority over general online recommendations.

Train every team member who performs or assists with treatment, and keep protocol documents accessible in the treatment area. When a product, cartridge, setting, or patient presentation falls outside the team’s usual process, pause to verify the appropriate approach with the manufacturer or supervising clinician.

Emage Medical offers training and practice support to help teams use aesthetic technologies consistently. Practices can use this support to review technique, reinforce documentation, and update procedures when product labeling or device instructions change.

What Results Can Patients Expect?

Microneedling with a growth factor serum is intended to support the skin’s natural repair process. Results usually develop in stages, not immediately after the appointment. Patients may notice redness, warmth, tightness, or mild swelling soon after treatment, while changes in texture, firmness, and fine lines may take several weeks to appear as collagen remodeling continues.

Set expectations during the consultation by explaining that recovery and visible results vary. Age, skin condition, treatment depth, device settings, serum formulation, treatment frequency, and aftercare can all affect the outcome. Clinical literature reports that some patients notice improvement within several weeks, but the timeline depends on the concern being treated and the protocol used. A review of microneedling applications and outcomes provides useful context for discussing expected progress without making promises.

Prepare Patients for Redness, Warmth, Tightness, Pinpoint Bleeding, and Swelling

Patients should expect treated skin to look and feel different immediately after microneedling. Redness and warmth are common, and tightness may develop as the skin begins to recover. Depending on needle depth, the number of passes, pressure, and treatment endpoint, some patients may also experience pinpoint bleeding or mild swelling.

Explain that these effects can be part of a normal short-term response, but patients should still monitor their skin. They should avoid unnecessary touching and follow the written aftercare plan. Since treated skin may remain sensitive for several days, recommend only the products approved for the procedure. Guidance from Face Beauty Science on post-microneedling skincare also emphasizes keeping the routine gentle during recovery.

Explain Barrier Recovery and Downtime During the First 24–72 Hours

The first 24 to 72 hours generally focus on barrier recovery. Patients may experience dryness, sensitivity, mild swelling, or continued redness during this period. The skin can also react more strongly to heat, friction, sweat, sunlight, and products containing irritating active ingredients.

Give patients clear instructions for cleansing, moisturizing, sun protection, exercise, and makeup use. They should follow the provider’s directions and the serum manufacturer’s labeled instructions rather than adding unapproved products. If redness or swelling becomes more painful, spreads, feels unusually hot, or continues longer than expected, patients should contact the practice. Microneedling aftercare guidance describes temporary redness and swelling as possible effects that may last for several days.

Track Collagen Remodeling and Texture Changes During Weeks 2–8

Once the initial recovery period passes, patients may begin noticing smoother texture, improved softness, and a more even appearance. These changes reflect ongoing repair and collagen remodeling, so they typically develop over several weeks. Fine lines, mild laxity, and acne-scar texture may require multiple sessions before the difference becomes easy to see.

Explain that a growth factor serum may support the treatment protocol, but it cannot guarantee a particular result. A randomized, double-blind study discussed by MDPen in its review of growth factor serums reported improvements in wrinkle depth, texture, and firmness after microneedling with topical growth factors, with some results visible around four weeks. Present this as evidence from a specific study, not as a promise for every patient or product.

Plan Treatment Series, Maintenance Sessions, and Proper Intervals

Many aesthetic concerns respond better to a planned series than to one appointment. The number of sessions and the time between them should reflect the patient’s goals, treatment depth, skin response, and practice protocol. Scheduling treatments too close together may not allow enough time for the skin to recover, while long gaps can make progress more difficult to evaluate.

Create a plan that includes baseline photographs, expected milestones, follow-up appointments, and criteria for modifying treatment. Discuss maintenance sessions after reviewing the patient’s response and ongoing needs. If the serum is intended for application immediately after microneedling, confirm its labeled use, storage requirements, and compatibility with the device protocol before including it in a recurring treatment plan.

Account for Age, Skin Condition, Device Settings, Serum, and Aftercare

Two patients receiving the same procedure may have different recovery periods and visible outcomes. Age, baseline collagen levels, skin sensitivity, acne scarring, pigmentation, hydration, and general health can influence the response. Needle depth, pressure, number of passes, and treatment endpoints also affect both downtime and results.

The serum formulation matters as well. Products may differ in source, concentration, sterility, stability, and intended use. Aftercare can influence comfort and recovery, especially when patients protect treated skin from the sun and follow the practice’s instructions. Document the complete protocol at every visit, including device settings, serum details, and patient-reported reactions. This helps the clinical team identify patterns and make thoughtful adjustments.

Use Image Pro® Skin Imaging Systems to Document Progress

Standardized imaging gives providers a more reliable way to assess progress than memory or casual photographs. Capture baseline images before the first session using consistent lighting, positioning, and camera settings. Repeat the process at follow-up visits so the team can compare visible changes in texture, redness, pigmentation, and other concerns over time.

Emage Medical’s Image Pro® Skin Imaging Systems can support consultations and progress documentation by helping practices visualize skin concerns and monitor treatment changes. Use imaging alongside patient feedback and clinical assessment, not as the only measure of success. Obtain appropriate consent before taking or storing photographs, and follow the practice’s privacy and recordkeeping procedures.

Set Expectations for Gradual, Variable Results

Patients should understand that microneedling with growth factor serum may improve the appearance of specific concerns, but it cannot stop natural aging or produce identical results for everyone. Texture and firmness may change gradually. Deeper scars, pronounced laxity, or significant pigmentation may require a different approach or a combination of treatments.

Use specific, measured language during consultations. Rather than promising perfect skin, describe the improvements the protocol is designed to support and explain when progress will be reviewed. Research on microneedling with topical growth factors found that the added formula may improve texture, but it does not establish a universal response for every product or patient, as shown in this peer-reviewed clinical study. Clear expectations help patients recognize normal recovery and report concerns promptly.

What Are the Risks, Side Effects, and Contraindications?

Growth factor serum may complement professional microneedling, but it does not eliminate the risks associated with creating temporary microchannels in the skin. Microneedling can cause expected inflammation during the healing process, while the serum may cause irritation, contact dermatitis, or an allergic response. Safety depends on the patient’s health, skin condition, treatment settings, product formulation, and handling procedures.

A thorough consultation should cover allergies, medications, previous procedures, skin conditions, wound-healing history, and any tendency to develop cold sores or raised scars. The practice should also confirm that the serum is labeled for its intended use. A standard cosmetic serum should not be considered sterile or suitable for freshly treated skin simply because it contains growth factors.

Product selection and documentation are equally important. Record the product name, lot number, expiration date, treatment area, device settings, and patient response. Follow the device and product manufacturers’ instructions, including protocols for CytoPen® and other microneedling technologies. Provide written aftercare instructions and a direct way for patients to report concerns. When a patient has a complex medical history or a possible contraindication, consult the appropriate licensed medical professional before proceeding.

Explain Short-Term Redness, Sensitivity, Dryness, Itching, and Swelling

Redness, warmth, tightness, sensitivity, mild swelling, dryness, and temporary itching can occur after microneedling. These effects often reflect the skin’s inflammatory and repair response, but their intensity varies with needle depth, the number of passes, treatment pressure, treatment area, and the patient’s baseline sensitivity.

Patients should know that treated skin may feel sunburned for a short time. Recommend gentle cleansing, an approved moisturizer, and broad-spectrum sun protection according to the practice’s aftercare protocol. Patients should avoid rubbing, picking, exfoliating, or applying unapproved active ingredients while the skin barrier recovers. A qualified provider can explain which products are appropriate during the first few days, when skin is especially sensitive, as described in this microneedling aftercare guide.

Manage Irritation, Allergic Reactions, Contact Dermatitis, and Patch-Test Limits

A growth factor serum may contain more than growth factors. Preservatives, peptides, fragrances, botanical ingredients, buffers, and other components may cause irritation or contact dermatitis. Watch for worsening burning, itching, rash, blistering, or swelling instead of assuming every reaction is part of normal healing.

A patch test on intact skin may identify some sensitivities, but it cannot predict every response after microneedling. Treated skin has increased permeability and may react differently than uninjured skin. A patch test should never be used to justify applying a nonsterile cosmetic serum into microchannels. If irritation develops during testing, stop using the product and follow medical guidance based on the patch-test recommendations from The Ordinary.

Prevent Infection and Contamination From Nonsterile Products or Handling

Microneedling temporarily disrupts the skin barrier, so contamination can introduce bacteria or other microorganisms. Risk may increase when staff use a product not designed for procedural application, reuse single-use components, touch sterile materials, or transfer serum between containers. A product marketed for topical skincare is not automatically sterile, even when its ingredients appear appropriate.

Use only a labeled, procedure-specific product that the device and product manufacturers permit for the intended application. Keep the setup clean, use single-use supplies where required, and prevent the dropper or applicator from touching skin, gloves, or work surfaces. Store and discard products according to the label. Practices should also review how a serum should be introduced during aftercare and whether patch testing is appropriate, as outlined in this serum guidance from MDPen.

Postpone Treatment for Active Acne, Infection, Eczema, Dermatitis, Sunburn, or Barrier Damage

Do not microneedle over active bacterial, viral, or fungal infections, open lesions, inflamed acne, eczema flares, dermatitis, sunburn, or visibly compromised skin. Creating microchannels through an active condition may spread inflammation or microorganisms and delay recovery. The same principle applies when recent peels, laser procedures, injectables, excessive sun exposure, or new skincare products have left the skin unusually irritated.

Reschedule when the skin has returned to a stable baseline, then reassess before treatment. During recovery, simple care is generally preferable to aggressive exfoliation or multiple active ingredients. A gentle cleanser, suitable hydration, and sun protection are commonly included in professional aftercare instructions, such as those described in this post-microneedling skincare guide.

Review Bleeding Risk, Medications, Immunosuppression, and Wound-Healing Concerns

Microneedling may produce pinpoint bleeding, particularly at deeper settings. Before treatment, review anticoagulants, antiplatelet medications, bleeding disorders, supplements that may affect bleeding, and any history of excessive bruising. Patients should not stop prescribed medication without direction from the clinician who manages that medication.

Ask about immune-suppressing medicines, active cancer treatment, radiation, chronic steroid use, and previous problems with wound healing. These factors may affect the skin’s ability to recover or increase infection risk. If the risk is unclear, pause treatment and obtain medical guidance. Document the discussion and any instructions from the prescribing clinician rather than making medication changes during the aesthetic appointment.

Assess Diabetes, Autoimmune Conditions, Pregnancy, Lactation, and Medical History

A complete intake should include diabetes, autoimmune disease, allergies, chronic skin conditions, pregnancy, lactation, current medications, and previous reactions to cosmetic or medical procedures. Poorly controlled diabetes may affect sensation and wound healing. Autoimmune conditions and their treatments may also change how the skin responds, although the decision depends on the individual’s diagnosis, treatment plan, and medical history.

Pregnancy and lactation require careful product review because serum ingredients, preservatives, and supporting compounds may have different safety considerations. If the formula lacks clear information for these populations, defer treatment or request guidance from the patient’s obstetric or primary care provider. Do not make broad assumptions based on the word “topical.” Review the complete ingredient list, product labeling, and patient history with a qualified provider, consistent with this dermatology guidance on growth factors.

Consider Keloid, Hypertrophic-Scar, and Pigment-Change Risks

Patients with a personal or family history of keloids or hypertrophic scars may face a higher risk of developing a raised scar after skin injury. Ask about previous surgical scars, piercings, and acne scars, as well as how those areas healed. A history of abnormal scarring does not automatically determine eligibility, but it calls for a careful assessment and, in some cases, medical referral.

Post-inflammatory hyperpigmentation or hypopigmentation may also occur, particularly after significant inflammation or sun exposure. Use conservative settings, avoid treating actively irritated skin, and provide clear sun-protection instructions. Explain that recovery and results can differ by skin type and condition. This peer-reviewed review of microneedling applications and outcomes also emphasizes the importance of individual patient factors.

Address Herpes Reactivation and Prolonged Redness

Skin injury may reactivate herpes simplex in patients with a history of cold sores, particularly when treating areas around the mouth. Ask about previous outbreaks during the consultation and follow the supervising clinician’s protocol for prevention or treatment. Do not treat an active outbreak, crusted lesion, or unexplained blistering.

Redness that becomes more intense, spreads, or lasts substantially longer than expected deserves assessment. Prolonged inflammation can indicate irritation, infection, dermatitis, or another complication rather than routine healing. Give patients a direct contact method and clear instructions for reporting changes. They should not try to conceal symptoms with irritating makeup or add unapproved products before the practice reviews the reaction.

Discuss Exosome Uncertainty and Unsupported Regenerative Claims

Exosome and secretome products are often discussed alongside growth factors, but they are not interchangeable with a well-characterized recombinant protein or a conventional conditioned-media formula. Source materials, manufacturing methods, purification, storage, sterility, and testing can vary widely. Claims about tissue regeneration, permanent rejuvenation, or guaranteed outcomes may go beyond the available evidence.

Evaluate the finished product, not just the ingredient category. Review labeling, quality controls, intended use, and evidence tied to the exact formulation and delivery method. Do not imply that microneedling makes an exosome product injectable or that increased absorption proves safety. Use cautious, evidence-based language and review relevant regulatory communications before making claims. Patients may also benefit from a plain explanation that growth factors and exosomes remain active areas of research.

Identify Red Flags That Require Prompt Medical Evaluation

Give patients a clear list of symptoms that warrant prompt contact with the practice or medical evaluation. These may include rapidly increasing pain, spreading redness, warmth, pus, fever, severe swelling, extensive blistering, hives, facial or eye swelling, difficulty breathing, or a reaction that continues to worsen instead of settling.

If breathing difficulty, swelling of the mouth or throat, or another sign of a severe allergic reaction occurs, the patient should seek emergency care immediately. For less urgent but concerning symptoms, instruct the patient to stop using the serum, avoid applying additional products, and contact the practice. The patch-test guidance from The Ordinary similarly advises stopping use and seeking medical help for severe irritation, hives, blistering, or breathing problems.

Document the onset, appearance, treatment area, products used, device settings, patient instructions, and follow-up outcome. A consistent adverse-event process helps the clinical team respond quickly and identify whether a product, technique, aftercare step, or patient-specific factor may have contributed.

How Can Practices Build a Safe, Consistent Protocol?

A growth factor serum should fit into a complete microneedling protocol, not function as a standalone add-on. Consistency starts before the device touches the patient’s skin and continues through follow-up. Every step should be written, teachable, and repeatable by qualified team members under appropriate clinical supervision.

Begin by defining which patients may be candidates, which products and devices are approved for use, and when treatment should be postponed. The protocol should cover skin assessment, medical history, product selection, treatment settings, serum application, aftercare, and escalation procedures. Microneedling outcomes can vary based on treatment depth, skin condition, product handling, and patient adherence. A review of microneedling techniques and applications in Dermatology and Therapy can support staff education and clinical discussions.

A well-designed process also helps the practice deliver a more consistent patient experience. The following steps provide a practical framework for creating and maintaining a protocol.

Create Standard Operating Procedures From Consultation Through Follow-Up

Write the SOP in the order the treatment occurs. Include consultation questions, medical history review, contraindication screening, baseline photographs, informed consent, skin preparation, device settings, serum application, aftercare, and follow-up timing. Identify which team members may complete each task and when a licensed provider must review or approve the treatment plan.

List the exact serum, intended use, storage requirements, lot number, expiration date, and device compatibility. Avoid vague instructions such as “apply serum after treatment.” Specify when to apply it, how much to use, whether it is intended for treated skin, and which handling steps are not permitted.

Review the SOP whenever the practice adds a product, changes a device, or identifies a recurring issue. A current, written process reduces variation and gives new team members a reliable reference.

Maintain Sterile Setup, Single-Use Handling, and Cross-Contamination Prevention

Microneedling creates temporary microchannels, so product handling requires more care than applying a serum to intact skin. Keep the treatment area clean and organized. Follow the product and device manufacturer’s instructions for hand hygiene, protective equipment, surface disinfection, and skin preparation.

Use only a serum labeled for the intended procedure. Do not transfer product between containers, reuse applicators, or return unused serum to its original package. Open single-use components immediately before treatment and discard them according to practice policy and applicable requirements. Keep containers away from gloves, devices, treatment surfaces, and other potential sources of contamination.

Check packaging, storage conditions, lot details, and expiration dates before beginning. If sterility or product integrity is uncertain, do not use the serum. Set it aside, contact the manufacturer, and document the decision.

Train Staff on Devices, Needle Depth, Passes, and Treatment Endpoints

Device training should cover more than turning the handpiece on and off. Each qualified provider should understand how needle depth, speed, pressure, passes, treatment pattern, and endpoint influence the skin response. Settings may vary by treatment area, skin condition, indication, and device instructions, so staff should not rely on one standard setting for every patient.

Use supervised practice to assess hand position, cartridge handling, skin tension, movement pattern, and serum application. Providers should know when to reduce intensity, stop treatment, or request clinical input. They should also recognize responses that fall outside the expected range.

Keep competency records for initial education, observed treatments, device-specific training, and periodic reassessment. Emage Medical’s microneedling technologies can support device discussions, while the practice remains responsible for following professional and regulatory requirements.

Document Competency, Informed Consent, and Written Aftercare

Complete records help protect patients and keep treatment consistent. Document the consultation findings, treatment indication, device and cartridge details, needle depth, number of passes, treatment areas, serum name, lot number, expiration date, and immediate skin response.

Informed consent should cover the treatment’s purpose, expected redness and sensitivity, possible downtime, variable outcomes, alternatives, and known risks. If evidence for a specific formula is limited, explain that clearly. Patients should understand that a topical serum is not an injectable product and that microneedling cannot guarantee a particular result.

Provide written aftercare instructions before the patient leaves. Include cleansing guidance, approved moisturizer use, sun protection, activities to avoid, products to pause, and signs that require a call to the practice. Ask the patient to repeat key instructions so staff can address confusion early.

Schedule Follow-Ups, Document Adverse Events, and Review Protocols

Set follow-up expectations before treatment begins. A phone call or message during the first few days can identify concerns while the skin recovers. A later visit or image comparison may help evaluate gradual changes in texture and tone. Timing should reflect treatment intensity, patient history, and the practice’s clinical standards.

Document unexpected pain, prolonged redness, swelling, itching, rash, acne flares, pigment changes, delayed healing, suspected infection, and patient complaints. Include symptom onset, products used, advice provided, provider notification, and outcome. Escalate concerns according to the practice’s clinical policy.

Review adverse events and near misses during quality meetings. Look for patterns involving a serum, device setting, treatment area, storage condition, or aftercare instruction. A clinical study of microneedling with topical growth factors may inform staff discussions, but patient monitoring and clinical judgment remain essential.

Educate Patients and Use Responsible Marketing Language

Explain what the serum is intended to do, how it fits into microneedling, and why results develop gradually. Use clear language to describe temporary microchannels, barrier recovery, and collagen remodeling. Avoid suggesting that a topical product has the same effect as an injection or can correct every skin concern.

Marketing claims should reflect evidence for the finished product, not only the reputation of an ingredient. Avoid guarantees, dramatic before-and-after promises, and statements that imply the treatment is risk-free. Language such as “may support” or “is intended to improve the appearance of” is more appropriate when patient responses vary.

Train front-desk and marketing teams to use the same descriptions as clinical staff. Emage Medical’s marketing support can help practices develop patient-facing materials that explain services responsibly. Have a qualified clinician review website copy, advertisements, and treatment descriptions before publication.

Use Emage Medical Training, Marketing Support, and Ongoing Practice Guidance

A protocol is easier to maintain when staff have access to device education, clinical guidance, and operational support. Emage Medical offers training and practice support to help aesthetic practices implement modern technologies with clear workflows and defined responsibilities.

Use training to review device operation, treatment setup, serum handling, documentation, aftercare, and troubleshooting. When introducing a new microneedling system or changing treatment settings, ask for device-specific guidance and provide supervised practice before offering the service independently.

Marketing support can connect clinical standards with the patient experience. Review consultation forms, website copy, treatment menus, and follow-up messages so they communicate consistent expectations. Keep manufacturer instructions, training records, product documentation, competency assessments, and internal reviews together for easy reference. Regular protocol reviews help the team refine its process while keeping patient safety and transparency at the center.

Frequently Asked Questions

What is growth factor serum used for during microneedling?
Growth factor serum is a topical product that may support hydration, comfort, and the skin’s recovery after microneedling. Some formulas contain growth factors, peptides, hyaluronic acid, conditioned media, or recombinant proteins. Practices should select a product specifically labeled for professional use and follow the device and serum manufacturer’s instructions.

Can any growth factor serum be used with a microneedling device?
No. A serum intended for use on intact skin may contain ingredients that irritate freshly treated skin or may not meet the handling requirements of a professional procedure. Confirm the product’s intended use, sterility, storage requirements, and compatibility with the specific device, such as CytoPen® or StemFacial® systems.

When should growth factor serum be applied?
Application timing depends on the product label and treatment protocol. Some products are designed for use during microneedling, while others are intended for immediate post-treatment application or later home care. Do not apply a serum through microneedling channels unless its labeling and the device protocol support that use.

What results can patients expect from microneedling with growth factor serum?
Patients may see gradual improvements in the appearance of hydration, texture, fine lines, firmness, or mild acne scars. Results vary based on the serum formulation, treatment settings, skin condition, treatment frequency, and aftercare. Growth factor serum does not replace injectables, surgery, or treatments for deeper scars and significant laxity.

What should practices document when using growth factor serum?
Record the patient assessment, informed consent, product name, lot number, expiration date, storage details, device settings, needle depth, number of passes, application timing, and aftercare instructions. Standardized photography and follow-up notes can help the team evaluate results and identify unexpected irritation or other reactions.